Camelot Portfolios LLC acquired a new stake in Markel Co. (NYSE:MKL) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 180 shares of the insurance provider’s stock, valued at approximately $213,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Lowe Brockenbrough & Co. Inc. boosted its stake in Markel by 2.4% in the 1st quarter. Lowe Brockenbrough & Co. Inc. now owns 1,944 shares of the insurance provider’s stock worth $1,937,000 after purchasing an additional 45 shares during the period. Nordea Investment Management AB boosted its stake in shares of Markel by 4.5% during the 1st quarter. Nordea Investment Management AB now owns 650 shares of the insurance provider’s stock worth $648,000 after buying an additional 28 shares during the last quarter. First Trust Advisors LP boosted its stake in shares of Markel by 186.8% during the 1st quarter. First Trust Advisors LP now owns 14,054 shares of the insurance provider’s stock worth $14,001,000 after buying an additional 9,153 shares during the last quarter. Amundi Pioneer Asset Management Inc. boosted its stake in shares of Markel by 0.6% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 9,658 shares of the insurance provider’s stock worth $9,622,000 after buying an additional 56 shares during the last quarter. Finally, Gulf International Bank UK Ltd boosted its stake in shares of Markel by 0.9% during the 2nd quarter. Gulf International Bank UK Ltd now owns 3,459 shares of the insurance provider’s stock worth $3,768,000 after buying an additional 30 shares during the last quarter. Institutional investors and hedge funds own 75.38% of the company’s stock.

A number of research firms have recently commented on MKL. ValuEngine downgraded shares of Markel from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Boenning Scattergood restated an “outperform” rating on shares of Markel in a research note on Monday, July 1st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. Markel presently has a consensus rating of “Hold” and a consensus target price of $1,130.25.

Shares of Markel stock traded down $9.04 during trading hours on Wednesday, reaching $1,136.29. 1,719 shares of the company’s stock were exchanged, compared to its average volume of 34,001. The company has a 50 day moving average of $1,164.31 and a two-hundred day moving average of $1,095.64. Markel Co. has a fifty-two week low of $950.16 and a fifty-two week high of $1,216.47. The company has a current ratio of 0.58, a quick ratio of 0.58 and a debt-to-equity ratio of 0.35. The stock has a market cap of $15.83 billion, a P/E ratio of 55.35 and a beta of 0.77.

Markel (NYSE:MKL) last issued its earnings results on Tuesday, July 30th. The insurance provider reported $11.84 earnings per share (EPS) for the quarter. The company had revenue of $2.01 billion for the quarter. Markel had a net margin of 9.07% and a return on equity of 7.38%. As a group, analysts expect that Markel Co. will post 37.15 earnings per share for the current fiscal year.

In other Markel news, Vice Chairman Steven A. Markel sold 2,955 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $1,111.37, for a total value of $3,284,098.35. Following the transaction, the insider now directly owns 98,132 shares of the company’s stock, valued at approximately $109,060,960.84. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Vice Chairman Steven A. Markel sold 1,368 shares of the stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $1,114.64, for a total transaction of $1,524,827.52. Following the completion of the transaction, the insider now directly owns 99,338 shares in the company, valued at $110,726,108.32. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 6,564 shares of company stock worth $7,432,845. 2.34% of the stock is owned by insiders.

Markel Profile

Markel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, the United Kingdom, Canada, and internationally. Its Insurance segment offers general and professional liability, property, personal lines, marine and energy, specialty programs, and workers' compensation insurance products.

Recommended Story: What is a good dividend yield?

Institutional Ownership by Quarter for Markel (NYSE:MKL)

Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.